Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics

Prior to Moderna, Stéphane was CEO of bioMérieux and he has also held leadership positions at Eli Lilly. Moderna claims it can generate proteins needed to treat an array of diseases by turning cells into “drug factories” with custom-built strands of messenger RNA. In 2017, Stéphane was named Ernst & Young 2017 New England Entrepreneur of the Year.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019